{"id":"NCT00475878","sponsor":"Butler Hospital","briefTitle":"SSRI and Buprenorphine","officialTitle":"Antidepressants During Office-Based Buprenorphine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2009-09","completion":"2009-09","firstPosted":"2007-05-21","resultsPosted":"2012-04-03","lastUpdate":"2012-04-03"},"enrollment":147,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Opiate Dependence","Depression"],"interventions":[{"type":"DRUG","name":"escitalopram","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"placebo","type":"PLACEBO_COMPARATOR"},{"label":"escitalopram","type":"ACTIVE_COMPARATOR"}],"summary":"This study is designed to test whether treatment of depressive symptoms using escitalopram improves adherence to Buprenorphine and reduces symptoms of depression for individuals receiving Buprenorphine through their medical provider.","primaryOutcome":{"measure":"Percentage of Participants Who Dropped Out of Buprenorphine Treatment","timeFrame":"3 months","effectByArm":[{"arm":"10 mg Escitalopram","deltaMin":33.3,"sd":null},{"arm":"Placebo","deltaMin":44,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":".19"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["24521036","23891461","22864399","21924552","21491290","20598836"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":75},"commonTop":[]}}